Rucaparib Impurity 13 | CAS 2306161-16-8 - Request Quote
Rucaparib Impurity 13
| SZ CAT No: | SZ-R055015 |
| CAS No | 2306161-16-8 |
| Mol.F. | C19H18FN3O2 |
| Mol.Wt. | 339.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rucaparib Impurity 13 is chemically (4-(8-fluoro-1-oxo-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-5-yl)benzyl)(methyl)oxidoazane. Rucaparib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Rucaparib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rucaparib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2306161-16-8
Purchase 2306161-16-8
Order 2306161-16-8
Enquire 2306161-16-8
price of 2306161-16-8
2306161-16-8 Supplier
2306161-16-8 Manufacturer
2306161-16-8 Exporter
buy high quality Rucaparib Impurity 13
Purchase Rucaparib Impurity 13
Rucaparib Impurity 13 suppliers
Rucaparib Impurity 13 manufacturers
Rucaparib Impurity 13 price
Order Rucaparib Impurity 13
Enquire Rucaparib Impurity 13
Rucaparib Impurity 13 cost
Rucaparib Impurity 13 Supplier
Rucaparib Impurity 13 Distributor
Rucaparib Impurity 13 for Method Validation
Rucaparib Reference Standard
Rucaparib Impurity 13 for ANDA Filing
Rucaparib Impurity 13 for Forced Degradation Studies
Rucaparib Impurity 13 Identification Standards
Rucaparib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


